Direct-Mail Self-Sampling Increases Uptake of Cervical Cancer Screening
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 30, 2023 -- For individuals who are due or overdue for cervical cancer screening, direct-mail human papillomavirus (HPV) self-sampling increases screening uptake, according to a study published in the Nov. 28 issue of the Journal of the American Medical Association.
Rachel L. Winer, Ph.D., M.P.H., from the University of Washington in Seattle, and colleagues examined the effectiveness of direct-mail and opt-in approaches for offering HPV self-sampling kits to individuals by cervical cancer screening history (due for screening, overdue, or unknown) in a randomized clinical trial involving women aged 30 to 64 years. Individuals stratified as due were randomly assigned to receive usual care (patient reminders and clinician electronic health record alerts), education (usual care plus educational materials), direct mail (usual care plus educational materials plus a mailed self-sampling kit), or opt-in (usual care plus educational materials and the option to request a kit; 3,671; 3,960; 1,482; and 3,956 participants, respectively). Individuals who were overdue were randomly assigned to usual care, education, or direct mail (5,488; 1,408; and 1,415 participants, respectively). Individuals with unknown screening history were randomly assigned to usual care, education, or opt-in (2,983; 3,486; and 3,506, respectively).
The researchers found that among those due for screening, screening completion was 14.1 and 3.5 percent higher in the direct-mail and opt-in groups, respectively, compared with receiving education alone. Screening completion was 16.9 percent higher in the direct-mail versus education-alone group among overdue individuals. Screening was 2.2 percent higher for the opt-in versus the education-alone group among those with unknown history.
"To increase screening adherence, systems implementing HPV self-sampling should prioritize direct-mail outreach for individuals who are due and overdue for screening," the authors write.
Two authors disclosed ties to UnitedHealthcare.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
CDC: Decrease in Maternal Mortality Rates Seen in 2022
THURSDAY, May 2, 2024 -- In 2022, there was a decrease in maternal mortality rates, according to a report published in the May Health E-Stats, a publication of the U.S. Centers...
Algorithm From EHR Can ID Common Variable Immunodeficiency Disease
THURSDAY, May 2, 2024 -- A machine learning algorithm can identify patients with common variable immunodeficiency disease (CVID) from their electronic health records, according to...
Video-Only Noninferior to In-Person Therapy After Thumb Carpometacarpal Arthroplasty
THURSDAY, May 2, 2024 -- For upper-extremity function after thumb carpometacarpal (CMC) arthroplasty, video-only therapy (VOT) is noninferior to in-person therapy (IPT), according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.